covid 19
Showing NaN - NaN of 1
COVID 19 Trial in Moscow (Colchicine, Ruxolitinib 5 MG, Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX])
Recruiting
- COVID 19
- Colchicine
- +3 more
-
Moscow, Moscow Region, Russian FederationLomonosov Moscow State University Medical Research and Education
May 26, 2020